Literature DB >> 12385015

Changing trends in incidence of lung cancer by histologic type in Scotland.

Elaine F Harkness1, David H Brewster, Keith M Kerr, Ron J Fergusson, Gary J MacFarlane.   

Abstract

Lung cancer is a major public health concern worldwide. Our study aims to examine trends in incidence of lung cancer in Scotland during 1959-97 and by histologic type for 1975-97. In Scotland, lung cancer is the most commonly diagnosed cancer in men and is the second most commonly diagnosed cancer in women. Due to poor survival rates, trends in incidence and mortality display similar patterns. Within the United States and many parts of Europe, falls in the incidence of squamous cell carcinoma have occurred whilst the incidence of adenocarcinoma has increased. Data were extracted from the Scottish Cancer Registry. Trends in incidence were examined by standardising rates to the World Standard Population. Age-specific rates were examined by year of diagnosis and mid year of birth. In Scotland the incidence of lung cancer in men has fallen since the late 1970s, whereas incidence in women has continued to increase. Incidence rates of adenocarcinoma have increased over time but squamous cell carcinoma remains the predominant type of lung cancer in Scotland. The quality of lung cancer registration data has improved over time, although a large proportion of lung cancers (>20%) are not microscopically verified. Changes in histologic types are unlikely to be solely due to diagnostic advances. Rates of adenocarcinoma have increased steadily over time, and this may be due to changes in cigarette design during the 1950s. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 12385015     DOI: 10.1002/ijc.10661

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

1.  The consequences of the unregulated cigarette.

Authors:  Nigel Gray
Journal:  Tob Control       Date:  2006-10       Impact factor: 7.552

2.  Do changes in cigarette design influence the rise in adenocarcinoma of the lung?

Authors:  David M Burns; Christy M Anderson; Nigel Gray
Journal:  Cancer Causes Control       Date:  2010-10-22       Impact factor: 2.506

3.  Chapter 7: Description of MISCAN-lung, the Erasmus MC Lung Cancer microsimulation model for evaluating cancer control interventions.

Authors:  F W Schultz; R Boer; H J de Koning
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

4.  Thyroid transcription factor 1 in pulmonary adenocarcinoma.

Authors:  G Stenhouse; N Fyfe; G King; A Chapman; K M Kerr
Journal:  J Clin Pathol       Date:  2004-04       Impact factor: 3.411

5.  Secular trends in incidence of lung cancer by histological type in Beijing, China, 2000-2016.

Authors:  Lei Yang; Ning Wang; Yannan Yuan; Shuo Liu; Huichao Li; Jing Tian; Jiafu Ji; Aiguo Ren
Journal:  Chin J Cancer Res       Date:  2019-04       Impact factor: 5.087

6.  DNA methylation changes in atypical adenomatous hyperplasia, adenocarcinoma in situ, and lung adenocarcinoma.

Authors:  Suhaida A Selamat; Janice S Galler; Amit D Joshi; M Nicky Fyfe; Mihaela Campan; Kimberly D Siegmund; Keith M Kerr; Ite A Laird-Offringa
Journal:  PLoS One       Date:  2011-06-23       Impact factor: 3.240

Review 7.  Prevalence of driver mutations in non-small-cell lung cancers in the People's Republic of China.

Authors:  Lan-Ying Gou; Yi-Long Wu
Journal:  Lung Cancer (Auckl)       Date:  2014-02-12

8.  Histological subtype of lung cancer in relation to socio-economic deprivation in South East England.

Authors:  Victoria A Bennett; Elizabeth A Davies; Ruth H Jack; Vivian Mak; Henrik Møller
Journal:  BMC Cancer       Date:  2008-05-19       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.